Skip to main content

Flex Pharma, Inc. (NASDAQ: FLKS) Investor Securities Class Action Lawsuit 06/19/2018

  • If you purchased shares of Flex Pharma, Inc. (NASDAQ: FLKS), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

December 10, 2018 - The case was voluntarily dismissed. June 9, 2018 - An investor in shares of Flex Pharma, Inc. (NASDAQ: FLKS) filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Flex Pharma, Inc. in connection with certain allegedly false and misleading statements made between November 6, 2017 and J...



You must register (for free) or login to view the entire case.